L

Lifevantage Corporation Common Stock (Delaware)

XNAS · Laboratory Analytical Instruments · S&P 500

$6.26

+$0.06 (+0.97%) today

Open $6.20 High $6.28 Low $6.16 Vol 61K Avg $6.22

Related Stocks

Find similar stocks by technical condition — S&P 500 universe

Symbol Company Name Exchange Currency Category
PMN ProMIS Neurosciences Inc. Common Shares (ON) XNAS USD PHARMACEUTICAL PREPARATIONS
EDSA Edesa Biotech, Inc. Common Shares XNAS USD PHARMACEUTICAL PREPARATIONS
KALV KalVista Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
GERN Geron Corp XNAS USD PHARMACEUTICAL PREPARATIONS
TELO Telomir Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
XNCR Xencor, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
INO Inovio Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AMPH Amphastar Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AXSM Axsome Therapeutics, Inc XNAS USD PHARMACEUTICAL PREPARATIONS
ANNX Annexon, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS

52-week price range

$3.90 $15.00

Price is 60.5% above its 52-week low and 58.3% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

  • Primary Exchange: XNAS
  • Market Cap: 70554293.72
  • Address:
  • Category: PHARMACEUTICAL PREPARATIONS
  • Total Employees: 238
  • Listing Date: 1997-03-10